Sage Journals: Discover world-class research

Free access

Review article

First published 2017-9

Midostaurin: a novel therapeutic agent for patients with FLT3-mutated acute myeloid leukemia and systemic mastocytosis

Molly M. Gallogly, Hillard M. Lazarus, Brenda W. Cooper

Therapeutic Advances in Hematology

Free access

Research article

First published 2021-8

Clinical implication and prognostic significance of FLT3-ITD and ASXL1 mutations in Egyptian AML patients: A single-center study

Huda F. Ebian, Sherin Elshorbagy, Haitham Mohamed [...]

Cancer Biomarkers

Open access

Review article

First published 2020

Gilteritinib in the treatment of relapsed and refractory acute myeloid leukemia with a FLT3 mutation

Serena Chew, Melissa C. Mackey, Elias Jabbour

Therapeutic Advances in Hematology

Open access

Case report

First published 2022-5

The FLT3 Y842D mutation may be highly sensitive to midostaurin: a case report

Shujiao He, Minjie Zhang, Jieying Li [...]

Journal of International Medical Research

Open access

Review article

First published 2019

Allogeneic transplant for FLT3 - ITD mutated AML: a focus on FLT3 inhibitors before,during,and after transplant

Abdul Hamid Bazarbachi, Rama Al Hamed, Florent Malard [...]

Therapeutic Advances in Hematology

Open access

Research article

First published 2020

High incidence of FLT3 mutations in follicular thyroid cancer: potential therapeutic target in patients with advanced disease stage

Martyna Borowczyk, Ewelina Szczepanek-Parulska, Szymon Dębicki [...]

Therapeutic Advances in Medical Oncology

Free access

Research article

First published 2010-4

Prevalence and Prognostic Significance of FLT3 Gene Mutations in Patients with Acute Leukaemia: Analysis of Patients from the Shanghai Leukaemia Co-operative Group

W Wang, X-Q Wang, X-P Xu [...]

Journal of International Medical Research

Open access

Research article

First published 2017

Cytogenetic Profile and FLT3 Gene Mutations of Childhood Acute Lymphoblastic Leukemia

Nawaf Alkhayat, Yasser Elborai, Omer Al Sharif [...]

Clinical Medicine Insights: Oncology

Retricted access

Case report

First published 2019-6

Isavuconazole therapy in an FLT3 mutated acute myeloid leukemia patient receiving midostaurin: A case report

Eris Tollkuci

Journal of Oncology Pharmacy Practice

Free access

Research article

First published 2012-7

The STAT5 Inhibitor Pimozide Displays Efficacy in Models of Acute Myelogenous Leukemia Driven by FLT3 Mutations

Erik A. Nelson, Sarah R. Walker, Michael Xiang [...]

Genes & Cancer

Search results